Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Napsin A is differentially expressed in sclerosing hemangiomas of the lung.

Schmidt LA, Myers JL, McHugh JB.

Arch Pathol Lab Med. 2012 Dec;136(12):1580-4. doi: 10.5858/arpa.2011-0486-OA.

PMID:
23194051
2.

[Histogenesis of pulmonary sclerosing hemangioma].

Sun Y, Zhou LX, Zhao M, Li XH.

Zhonghua Bing Li Xue Za Zhi. 2012 Apr;41(4):239-42. doi: 10.3760/cma.j.issn.0529-5807.2012.04.006. Chinese.

PMID:
22800519
3.

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.

Bishop JA, Sharma R, Illei PB.

Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8.

PMID:
19740516
5.

Polyclonal napsin A expression: a potential diagnostic pitfall in distinguishing primary from metastatic mucinous tumors in the lung.

Heymann JJ, Hoda RS, Scognamiglio T.

Arch Pathol Lab Med. 2014 Aug;138(8):1067-71. doi: 10.5858/arpa.2013-0403-OA.

PMID:
25076295
6.

TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.

Aulakh KS, Chisholm CD, Smith DA, Speights VO.

Arch Pathol Lab Med. 2013 Aug;137(8):1094-8. doi: 10.5858/arpa.2012-0305-OA.

PMID:
23899066
7.

Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.

Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):313-7. doi: 10.1097/PAI.0b013e318205b059.

PMID:
21464700
8.

A word of caution regarding napsin A expression in squamous cell carcinomas of the lung.

Ordóñez NG.

Am J Surg Pathol. 2012 Mar;36(3):396-401. doi: 10.1097/PAS.0b013e31823b13e2.

PMID:
22198009
9.

Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.

Shi J, Liu H, Ma XJ, Chen Z, He MX, Luo Y, Lin F.

Arch Pathol Lab Med. 2016 Apr;140(4):332-40. doi: 10.5858/arpa.2014-0644-OA.

PMID:
27028392
10.

Sclerosing hemangioma of the lung.

Keylock JB, Galvin JR, Franks TJ.

Arch Pathol Lab Med. 2009 May;133(5):820-5. doi: 10.1043/1543-2165-133.5.820. Review.

PMID:
19415961
11.

Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):155-62. doi: 10.5858/arpa.2011-0232-OA.

PMID:
22288962
12.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
13.

Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.

Kadivar M, Boozari B.

Appl Immunohistochem Mol Morphol. 2013 May;21(3):191-5. doi: 10.1097/PAI.0b013e3182612643.

PMID:
22914608
14.

Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.

Rossi G, Cavazza A, Righi L, Sartori G, Bisagni A, Longo L, Pelosi G, Papotti M.

Int J Surg Pathol. 2014 Aug;22(5):401-7. doi: 10.1177/1066896914527609. Epub 2014 Mar 19.

15.

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.

Brown AF, Sirohi D, Fukuoka J, Cagle PT, Policarpio-Nicolas M, Tacha D, Jagirdar J.

Arch Pathol Lab Med. 2013 Sep;137(9):1274-81. doi: 10.5858/arpa.2012-0635-OA. Epub 2013 Jan 4.

PMID:
23289761
16.

[Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].

Xu X, Liu H, Jiang H, Li C, Yuan S, Yang J.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Nov;35(11):1610-3. Chinese.

PMID:
26607085
17.

Napsin A expression in pulmonary sclerosing haemangioma.

Rossi G, Cadioli A, Mengoli MC, Piccioli S, Cavazza A.

Histopathology. 2012 Jan;60(2):361-3. doi: 10.1111/j.1365-2559.2011.03983.x. Epub 2011 Nov 10. No abstract available.

PMID:
22074388
18.

Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.

Chernock RD, El-Mofty SK, Becker N, Lewis JS Jr.

Am J Surg Pathol. 2013 Aug;37(8):1215-22. doi: 10.1097/PAS.0b013e318283b7b2.

PMID:
23681073
19.

Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.

Nishino M, Hoang MP, Della Pelle P, Morales-Oyarvide V, Huynh TG, Mark EJ, Mino-Kenudson M.

Cancer Cytopathol. 2016 Jul;124(7):472-84. doi: 10.1002/cncy.21707. Epub 2016 Feb 29.

20.

Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.

Mukhopadhyay S, Katzenstein AL.

Am J Clin Pathol. 2012 Nov;138(5):703-11. doi: 10.1309/AJCPKVBXTI9O3TEM.

PMID:
23086771

Supplemental Content

Support Center